Just over a year after its first phase 3 trial of its Engensis gene therapy for painful diabetic peripheral neuropathy (DPN) bombed, Helixmith has started dosing patients in a new study.

Dip Pen Nanolithography ® (DPN ™) is the controlled delivery of ... polymers for research into cell-adhesion properties 3. Hydrogels are three-dimensional cross-linked polymer networks that ...